News Releases

Leading New Gene-based Therapies

Enochian Biosciences Announces Uplisting to NASDAQ Under Symbol “ENOB”

December 5, 2018

Enochian Biosciences Attending 60th ASH on Nov 30-Dec 4 in San Diego, CA

November 27, 2018

Enochian Biosciences to Present at Biotech Showcase 2019

November 23, 2018

Enochian Biosciences Attending Cell & Gene Meeting on the Mesa on October 3-5, 2018 in La Jolla, California.

September 4, 2018

Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board

July 3, 2018

Dandrit Biotech announces filing of listing application to the Nasdaq capital market

February 23, 2018

Dandrit Biotech announces completion of the acquisition of Enochian

February 20, 2018

Dandrit Biotech announces acquisition of Enochian New York, NY

January 17, 2018

DanDrit Biotech USA Inc. Announces new Therapeutic Research Strategy

June 12, 2017

Dr. Eric Leire, CEO of DanDrit Biotech, will be a Speaker September 22 at 13:30 Denmark Time

September 22, 2015

DanDrit Biotech to Present at, Cancer Vaccines Advancing Immuno-oncology

September 16, 2015

DanDrit Biotech Analyst Coverage Initiated: Report Issued by Nordic Bio Investor.

July 17, 2015